Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1980 Aug;18(2):264–268. doi: 10.1128/aac.18.2.264

Substrate-labeled fluorescent immunoassay for amikacin in human serum.

S G Thompson, J F Burd
PMCID: PMC283981  PMID: 7004339

Abstract

A homogeneous substrate-labeled fluorescent immunoassay has been developed to measure amikacin levels in human serum. Amikacin is covalently labeled with the fluorogenic enzyme substrate beta-galactosyl-umbelliferone. This beta-galactosyl-umbelliferone-amikacin conjugate is nonfluorescent under assay conditions until it is hydrolyzed by beta-galactosidase to yield a fluorescent product. When antiserum to amikacin binds the substrate-labeled drug, the antibody complex formation inhibits hydrolysis of the fluorogenic substrate. Reaction mixtures containing a constant level of substrate-labeled amikacin and a limiting amount of antiserum enable labeled and unlabeled amikacin to compete for the antibody-binding sites. Unbound substrate-labeled drug is hydrolyzed by the enzyme to release a fluorescent product that is proportional to the unlabeled amikacin concentration. The amikacin levels found in clinical serum samples with this method were comparable (r = 0.987) to those obtained by radioimmunoassay. The fluorescent immunoassay is rapid and simple to perform and requires only 2 microliters of serum.

Full text

PDF
264

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barza M., Scheife R. T. Drug therapy reviews: Antimicrobial spectrum, pharmacology and therapeutic use of antibiotics--part 4: aminoglycosides. Am J Hosp Pharm. 1977 Jul;34(7):723–737. [PubMed] [Google Scholar]
  2. Burd J. F., Wong R. C., Feeney J. E., Carrico R. J., Boguslaski R. C. Homogeneous reactant-labeled fluorescent immunoassay for therapeutic drugs exemplified by gentamicin determination in human serum. Clin Chem. 1977 Aug;23(8):1402–1408. [PubMed] [Google Scholar]
  3. Lerner S. A., Seligsohn R., Matz G. J. Comparative clinical studies of ototoxicity and nephrotoxicity of amikacin and gentamicin. Am J Med. 1977 Jun;62(6):919–923. doi: 10.1016/0002-9343(77)90661-1. [DOI] [PubMed] [Google Scholar]
  4. Lewis J. E., Nelson J. C., Elder H. A. Amikacin: a rapid and sensitive radioimmunoassay. Antimicrob Agents Chemother. 1975 Jan;7(1):42–45. doi: 10.1128/aac.7.1.42. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Lewis J. E., Nelson J. C., Elder H. A. Radioimmunoassay of an antibiotic: gentamicin. Nat New Biol. 1972 Oct 18;239(94):214–216. doi: 10.1038/newbio239214a0. [DOI] [PubMed] [Google Scholar]
  6. Maitra S. K., Yoshikawa T. T., Steyn C. M., Guze L. B., Schotz M. C. Amikacin assay in serum by high-performance liquid chromatography. Antimicrob Agents Chemother. 1978 Dec;14(6):880–885. doi: 10.1128/aac.14.6.880. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Marengo P. B., Wilkins J., Overturf G. D. Rapid, specific microbiological assay for amikacin (BB-K8). Antimicrob Agents Chemother. 1974 Oct;6(4):498–500. doi: 10.1128/aac.6.4.498. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Scarbrough E., Williams J. W., Northrop D. B. Spectrophotometric assay for amikacin using purified kanamycin acetyltransferase. Antimicrob Agents Chemother. 1979 Aug;16(2):221–224. doi: 10.1128/aac.16.2.221. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Stevens P., Young L. S., Hewitt W. L. 125I-Radioimmunoassay of amikacin and comparison with a microbioassay. J Antibiot (Tokyo) 1976 Aug;29(8):829–832. doi: 10.7164/antibiotics.29.829. [DOI] [PubMed] [Google Scholar]
  10. Wong R. C., Burd J. F., Carrico R. J., Buckler R. T., Thoma J., Boguslaski R. C. Substrate-labeled fluorescent immunoassay for phenytoin in human serum. Clin Chem. 1979 May;25(5):686–691. [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES